Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin

In recent years, vasopressin has been increasingly used as an early treatment of vasopressor-refractory septic shock. In this article, we describe 2 episodes of transient diabetes insipidus after vasopressin for the treatment of septic shock was discontinued, which adds to a modest number of case st...

Descripción completa

Detalles Bibliográficos
Autores principales: Urban, Jacqueline A., Zirille, Francis, Kiser, Tyree H., Aschner, Yael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246092/
https://www.ncbi.nlm.nih.gov/pubmed/35782522
http://dx.doi.org/10.7326/aimcc.2022.0087
_version_ 1784738891737071616
author Urban, Jacqueline A.
Zirille, Francis
Kiser, Tyree H.
Aschner, Yael
author_facet Urban, Jacqueline A.
Zirille, Francis
Kiser, Tyree H.
Aschner, Yael
author_sort Urban, Jacqueline A.
collection PubMed
description In recent years, vasopressin has been increasingly used as an early treatment of vasopressor-refractory septic shock. In this article, we describe 2 episodes of transient diabetes insipidus after vasopressin for the treatment of septic shock was discontinued, which adds to a modest number of case studies reporting the same phenomenon. With the anticipated continued use of vasopressin in intensive care units, it can be expected that this adverse effect will occur with some frequency. Awareness and early recognition of this phenomenon can lead to prompt diagnosis and treatment.
format Online
Article
Text
id pubmed-9246092
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-92460922022-06-30 Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin Urban, Jacqueline A. Zirille, Francis Kiser, Tyree H. Aschner, Yael Ann Intern Med Clin Cases Article In recent years, vasopressin has been increasingly used as an early treatment of vasopressor-refractory septic shock. In this article, we describe 2 episodes of transient diabetes insipidus after vasopressin for the treatment of septic shock was discontinued, which adds to a modest number of case studies reporting the same phenomenon. With the anticipated continued use of vasopressin in intensive care units, it can be expected that this adverse effect will occur with some frequency. Awareness and early recognition of this phenomenon can lead to prompt diagnosis and treatment. 2022 2022-06-07 /pmc/articles/PMC9246092/ /pubmed/35782522 http://dx.doi.org/10.7326/aimcc.2022.0087 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND), which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. See: https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Article
Urban, Jacqueline A.
Zirille, Francis
Kiser, Tyree H.
Aschner, Yael
Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin
title Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin
title_full Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin
title_fullStr Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin
title_full_unstemmed Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin
title_short Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin
title_sort why so salty? transient diabetes insipidus after discontinuation of vasopressin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246092/
https://www.ncbi.nlm.nih.gov/pubmed/35782522
http://dx.doi.org/10.7326/aimcc.2022.0087
work_keys_str_mv AT urbanjacquelinea whysosaltytransientdiabetesinsipidusafterdiscontinuationofvasopressin
AT zirillefrancis whysosaltytransientdiabetesinsipidusafterdiscontinuationofvasopressin
AT kisertyreeh whysosaltytransientdiabetesinsipidusafterdiscontinuationofvasopressin
AT aschneryael whysosaltytransientdiabetesinsipidusafterdiscontinuationofvasopressin

Ejemplares similares